Profile data is unavailable for this security.
About the company
Neola Medical AB, formerly GPX Medical AB is a Sweden-based company that is involved in development of medical instruments. The Company's business concept is to commercialize the Company's medical technology product for continuous lung monitoring based on the patented GASMAS (Gas in Scattering Media Absorption Spectroscopy) technology. Neola Medical's technology equipment aims for continuous monitoring of the lungs of premature babies. The primary purpose of Neola Medical is to support neonatal intensive care with NEOLA, a medical device that can offer continuous lung monitoring and real-time alerts about life-threatening complications using new technology that measures lung volume changes and oxygen concentration.
- Revenue in SEK (TTM)0.00
- Net income in SEK-9.39m
- Incorporated2016
- Employees7.00
- LocationNeola Medical ABIdeon Science Park, Scheelevagen 27LUND 223 63SwedenSWE
- Phone+46 46540540
- Websitehttps://www.neolamedical.se/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Iconovo AB | 2.92m | -40.21m | 106.55m | 28.00 | -- | 0.7154 | -- | 36.54 | -2.74 | -2.74 | 0.196 | 7.02 | 0.0215 | -- | 1.14 | 100,561.70 | -29.61 | -25.43 | -33.16 | -28.24 | 635.97 | 134.57 | -1,378.66 | -215.16 | -- | -1,179.07 | 0.0668 | -- | -58.65 | -9.88 | 4.71 | -- | 34.70 | -- |
| Luxbright AB | 4.20m | -22.23m | 110.43m | 10.00 | -- | 3.71 | -- | 26.28 | -0.24 | -0.24 | 0.0454 | 0.2641 | 0.104 | -- | 4.14 | 420,270.00 | -55.02 | -61.39 | -62.23 | -70.36 | -134.43 | -577.85 | -528.90 | -2,529.11 | 0.7743 | -4,539.47 | 0.0084 | -- | 55.58 | -- | -20.07 | -- | -- | -- |
| Vo2 Cap Holding AB (publ) | 348.03m | -55.15m | 112.06m | 94.00 | -- | 0.6226 | -- | 0.322 | -0.9759 | -0.9759 | 6.46 | 3.16 | 0.7992 | -- | 8.21 | 3,378,952.00 | -12.66 | -0.2564 | -17.29 | -0.3839 | 35.78 | 23.36 | -15.84 | -0.2409 | -- | -6.95 | 0.1429 | -- | -26.09 | 85.65 | -57.92 | -- | -17.96 | -- |
| BibbInstruments AB | 0.00 | -12.21m | 116.81m | 4.00 | -- | 3.63 | -- | -- | -0.4477 | -0.4477 | 0.00 | 1.10 | 0.00 | -- | -- | -- | -34.78 | -39.57 | -36.66 | -42.71 | -- | 59.36 | -- | -8,032.40 | 4.41 | -- | 0.00 | -- | -- | -- | 2.72 | -- | -1.94 | -- |
| Q linea AB | 2.27m | -218.33m | 128.88m | 97.00 | -- | 5.02 | -- | 56.88 | -1.87 | -1.87 | 0.0194 | 0.219 | 0.0107 | 0.1224 | 3.01 | 17,842.52 | -103.05 | -59.66 | -149.74 | -66.14 | -124.10 | -378.58 | -9,635.17 | -4,046.97 | 0.4141 | -- | 0.7825 | -- | -65.28 | 33.02 | 14.64 | -- | 41.94 | -- |
| Glycorex Transplantation AB (publ) | 31.03m | -27.83m | 129.17m | 15.00 | -- | 3.53 | -- | 4.16 | -0.3768 | -0.3768 | 0.4201 | 0.5186 | 0.412 | 0.8382 | 3.69 | 1,348,913.00 | -36.96 | -11.30 | -46.32 | -13.17 | 82.91 | 91.60 | -89.70 | -33.24 | 1.09 | -71.86 | 0.2084 | -- | -17.04 | -2.15 | -254.06 | -- | -0.5593 | -- |
| Arcoma AB | 171.33m | 12.98m | 144.38m | 32.00 | 11.12 | 2.45 | 7.05 | 0.8427 | 0.9844 | 0.9844 | 12.99 | 4.48 | 1.87 | 3.48 | 7.87 | 5,526,807.00 | 14.18 | 1.12 | 24.21 | 2.01 | 38.29 | 37.66 | 7.58 | 0.7568 | 1.24 | 25.82 | 0.00 | 0.00 | 30.36 | 6.41 | 34.81 | -- | 22.75 | -- |
| SpectraCure AB (publ) | 2.36m | -21.18m | 153.66m | 13.00 | -- | 1.30 | -- | 65.00 | -0.218 | -0.218 | 0.0243 | 1.21 | 0.0166 | -- | 24.63 | 157,600.00 | -14.82 | -12.75 | -15.91 | -13.62 | 442.39 | 195.30 | -895.85 | -494.40 | -- | -- | 0.0494 | -- | -3.30 | -- | 19.46 | -- | -- | -- |
| Toleranzia AB | 0.00 | -7.12m | 153.91m | 11.00 | -- | 0.7548 | -- | -- | -0.0361 | -0.0361 | 0.00 | 0.7526 | 0.00 | -- | -- | 0.00 | -4.31 | -7.45 | -4.56 | -7.78 | -- | -- | -- | -- | -- | -- | 0.0481 | -- | -- | -- | 11.79 | -- | 63.90 | -- |
| Bactiquant A/S | 13.96m | -22.50m | 154.76m | -- | -- | 14.59 | -- | 11.09 | -0.6558 | -0.6558 | 0.4064 | 0.2906 | 0.5101 | 2.94 | 5.06 | -- | -82.23 | -41.26 | -92.65 | -47.16 | -24.34 | 12.89 | -161.20 | -71.77 | 2.73 | -9.48 | 0.5326 | -- | -0.689 | -- | 7.62 | -- | -- | -- |
| Nanexa AB | 26.66m | -64.42m | 178.44m | 16.00 | -- | 2.16 | -- | 6.69 | -0.6156 | -0.6156 | 0.2087 | 0.6084 | 0.2333 | -25.66 | 3.49 | 1,403,211.00 | -56.37 | -40.77 | -74.68 | -48.77 | 113.04 | 77.27 | -241.64 | -532.26 | 1.90 | -- | 0.0149 | -- | 925.42 | 147.00 | -30.44 | -- | 39.10 | -- |
| Neola Medical AB | 0.00 | -9.39m | 190.81m | 7.00 | -- | 2.67 | -- | -- | -0.141 | -0.141 | 0.00 | 1.02 | 0.00 | -- | -- | 0.00 | -12.96 | -17.04 | -13.98 | -18.46 | -- | 4,237.20 | -- | -5,258.78 | -- | -- | 0.00 | -- | -- | -- | 12.97 | -- | 55.46 | -- |
| INIFY Laboratories AB | 9.43m | -51.85m | 211.19m | 26.00 | -- | 4.43 | -- | 22.41 | -1.15 | -1.15 | 0.2086 | 1.05 | 0.1164 | 2.16 | 1.83 | -- | -64.03 | -- | -64.03 | -- | 84.45 | -- | -550.10 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Micropos Medical AB (publ) | 2.55m | -23.03m | 217.49m | 9.00 | -- | 14.79 | -- | 85.42 | -0.1536 | -0.1536 | 0.017 | 0.0964 | 0.1238 | 0.1034 | 2.09 | 318,247.50 | -112.02 | -64.24 | -154.79 | -82.27 | 82.20 | 114.76 | -904.59 | -767.57 | 2.73 | -- | 0.0249 | -- | 50.23 | 5.94 | -26.57 | -- | -- | -- |
| Boule Diagnostics AB | 563.33m | -212.52m | 262.51m | 227.00 | -- | 1.03 | -- | 0.466 | -5.48 | -5.48 | 14.17 | 6.56 | 0.8515 | 4.58 | 3.95 | 2,470,741.00 | -32.14 | 1.67 | -48.62 | 2.40 | 45.14 | 43.50 | -37.74 | 2.04 | 0.7686 | -24.41 | 0.4116 | 42.24 | 4.24 | 6.13 | 96.24 | -9.45 | -9.74 | -- |
| Scandinavian Medical Solutions A/S | 306.81m | 8.34m | 272.55m | 25.00 | 32.50 | 2.27 | 14.48 | 0.8884 | 0.1963 | 0.1963 | 7.22 | 2.81 | 1.38 | 1.89 | 11.35 | -- | 3.75 | -- | 6.15 | -- | 24.48 | -- | 2.72 | -- | 0.4307 | 5.54 | 0.3473 | -- | 72.98 | -- | 7.49 | -- | -- | -- |
Data as of Nov 22 2024. Currency figures normalised to Neola Medical AB's reporting currency: Swedish Krona SEK
0.02%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| FCG Fonder ABas of 31 Oct 2024 | 15.74k | 0.02% |
Data from 31 Oct 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
